Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Resnick

Showing results (271-280 of 276) with videos related to

Pageof 28
Sort By:
You have reached the last page of results.This site can display upto 276 results.
Cancer Research|July 1, 1996
CWR22: the first human prostate cancer xenograft with strongly androgen-dependent and relapsed strains both in vivo and in soft agarM Nagabhushan, C M Miller, T P Pretlow, et al.
The Journal of Urology|June 24, 1999
Have complication rates decreased after treatment for localized prostate cancer?I M Thompson, R G Middleton, S A Optenberg, et al.
Current Biology : CB|July 13, 2001
Rescue of a telomere length defect of Nijmegen breakage syndrome cells requires NBS and telomerase catalytic subunitV Ranganathan, W F Heine, D N Ciccone, et al.
In Vitro Cellular & Developmental Biology. Animal|January 30, 2004
Growth, immortalization, and differentiation potential of normal adult human proximal tubule cellsDavid E Orosz, Philip G Woost, Robert J Kolb, et al.
Cancer Research|August 17, 2000
Prostate cancer and other xenografts from cells in peripheral blood of patientsT G Pretlow, S Schwartz, J M Giaconia, et al.
The Journal of Pediatrics|July 1, 1997
Clinical spectrum of X-linked hyper-IgM syndromeJ Levy, T Espanol-Boren, C Thomas, et al.
Pageof 28

Showing results (271-280 of 276) with videos related to

Sort By:
Pageof 28
You have reached the last page of results.This site can display upto 276 results.
Cancer Research|July 1, 1996
CWR22: the first human prostate cancer xenograft with strongly androgen-dependent and relapsed strains both in vivo and in soft agarM Nagabhushan, C M Miller, T P Pretlow, et al.
The Journal of Urology|June 24, 1999
Have complication rates decreased after treatment for localized prostate cancer?I M Thompson, R G Middleton, S A Optenberg, et al.
Current Biology : CB|July 13, 2001
Rescue of a telomere length defect of Nijmegen breakage syndrome cells requires NBS and telomerase catalytic subunitV Ranganathan, W F Heine, D N Ciccone, et al.
In Vitro Cellular & Developmental Biology. Animal|January 30, 2004
Growth, immortalization, and differentiation potential of normal adult human proximal tubule cellsDavid E Orosz, Philip G Woost, Robert J Kolb, et al.
Cancer Research|August 17, 2000
Prostate cancer and other xenografts from cells in peripheral blood of patientsT G Pretlow, S Schwartz, J M Giaconia, et al.
The Journal of Pediatrics|July 1, 1997
Clinical spectrum of X-linked hyper-IgM syndromeJ Levy, T Espanol-Boren, C Thomas, et al.
Pageof 28